Imperva's (IMPV) Sale Process Said on Hold - Bloomberg

October 19, 2016 6:55 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Imperva's (NYSE: IMPV) sale process is on hold, as potential suitors wait to see if the company's growth can improve enough to justify a higher price, according to a report from Bloomberg late on Tuesday. The report said expectations in terms of deal value have been raised given recovery in sales projections since pre-announcing disappointing second-quarter results.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors

Add Your Comment